Search results
7 gru 2017 · The overall absolute increase in breast cancers diagnosed among current and recent users of any hormonal contraceptive was 13 (95% CI, 10 to 16) per 100,000 person-years, or approximately 1...
- Review Article Necrotizing Soft-Tissue Infections D.L. Stevens and A.E. Bryant
Necrotizing infections can occur after major traumatic...
- Images in Clinical Medicine Pneumatosis Cystoides Intestinalis Y. Sugihara and H. Okada
A 48-year-old woman with a prolonged history of...
- Editorial Closing In on Treatment for Hemophilia B M. Porteus
Hemophilia is an X-linked recessive genetic bleeding...
- Perspective Clinical Firsts — Christiaan Barnard's Heart Transplantations S. McKellar
On December 3, 1967, South African cardiac surgeon...
- Original Article Pharmacomechanical Catheter-Directed Thrombolysis for Deep-Vein Thrombosis S. Vedantham and Others
The post-thrombotic syndrome frequently develops in patients...
- Editorial Oral Contraceptives and The Small Increased Risk of Breast Cancer D.J. Hunter
In this issue of the Journal, Mørch et al. 1 present the...
- Clinical Problem-Solving An Unusual Cause of Leg Pain N.P. Kelly and Others
A 67-year-old woman presented to her primary care physician...
- Perspective How to Think About “Medicare for All J.A. Morone
Florent Nkouaga, How Did Medicare for All Influence Trump’s...
- Review Article Necrotizing Soft-Tissue Infections D.L. Stevens and A.E. Bryant
This study found that the overall risk of breast cancer among hormonal contraceptive users is low. Because of the low baseline risks in the age groups using hormonal contraception (ie, premenopausal women), the risk difference between hormonal contraception users and nonusers is small.
21 mar 2023 · The mean time between the last hormonal contraceptive prescription and diagnosis of breast cancer (or equivalent date for controls) was 3.1 (SD 3.7) years. Fig 1 shows the OR for breast cancer associated with one or more prescriptions by the type of hormonal contraceptive last prescribed.
2 paź 2024 · The average lifetime risk is approximately 70%, with more than half of all breast cancers in these women occurring before age 50 years. 1 Understanding whether and how use of hormonal contraception (HC) might affect these risks is important for informed decision making.
6 dni temu · A new study has found a link between hormonal intrauterine devices (IUDs) and breast cancer. But media reports of a large increase in risk may cause unnecessary worry.
23 wrz 2022 · A total of 2900 premenopausal women with early breast cancer (mean [SD] age at diagnosis, 43.1 [5.6] years) were included in the present analysis (Figure 1; Table 1). At diagnosis, 2088 of 2661 patients (78.5%) had partnered status, and 2498 of 2602 patients (96.0%) had children.
6 dni temu · During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use,...
